Golimumab FDA Approved for Psoriatic Arthritis, Ankylosing Spondylitis
This is the only fully human anti-TNF-α infused therapy approved for psoriatic arthritis, ankylosing spondylitis, and rheumatoid arthritis.
Arthritis Advocates Call on Congress
Rheumatology leaders prescribe legislative fixes for drug cost and access issues.
Arthritis Tracking Web and Mobile App Hits Recruitment Mark
The first patient-led, patient-centered research registry for joint, bone, and inflammatory skin conditions enrolls 11,000 patients.
Rheumatoid Arthritis Has Unseen Symptoms, Survey Says
A majority of patients said they found it difficult to explain the “invisible” aspects to others.
Psoriasis Severity Tied to Death Risk
This study was the first to use an objective measure to link severity of psoriasis and risk of death.
Ibuprofen Elevates Blood Pressure in Arthritis
Hypertension goes up more than with celecoxib in patients who are at increased risk for cardiovascular disease.
Duzallo Gains FDA Nod for Hyperuricemia in Uncontrolled Gout
This is the first FDA-approved fixed-dose combination treatment that addresses both overproduction and underexcretion of serum uric acid in a single pill.
Actemra for Giant Cell Arteritis Study Data Published
The need to find an alternative to prolonged periods of steroid therapy was addressed.
Orencia Gains Psoriatic Arthritis Approval in Europe
Patients demonstrated improved disease response in 2 clinical trials.
Benlysta Formulation for Lupus Gets FDA Nod
The first subcutaneous self-injection treatment option for patients with SLE has received approval.
By clicking Accept, you agree to become a member of the UBM Medica Community.